These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26440900)

  • 1. Anatomical and physiological basis for the allometric scaling of cisplatin clearance in dogs.
    Achanta S; Sewell A; Ritchey JW; Broaddus K; Bourne DW; Clarke CR; Maxwell LK
    J Vet Pharmacol Ther; 2016 Jun; 39(3):224-36. PubMed ID: 26440900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allometric scaling of pegylated liposomal anticancer drugs.
    Caron WP; Clewell H; Dedrick R; Ramanathan RK; Davis WL; Yu N; Tonda M; Schellens JH; Beijnen JH; Zamboni WC
    J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):653-69. PubMed ID: 21863380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.
    Funakoshi Y; Fujiwara Y; Kiyota N; Mukohara T; Shimada T; Toyoda M; Imamura Y; Chayahara N; Tomioka H; Umezu M; Otsuki N; Nibu K; Minami H
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):281-8. PubMed ID: 26791871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of cisplatin: interactions with organic anions and cations in the dog.
    Klein J; Bentur Y; Cheung D; Moselhy G; Koren G
    Clin Invest Med; 1991 Oct; 14(5):388-94. PubMed ID: 1742916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular filtration rate estimated by 3-sample plasma clearance of iohexol in 118 healthy dogs.
    Bexfield NH; Heiene R; Gerritsen RJ; Risøen U; Eliassen KA; Herrtage ME; Michell AR
    J Vet Intern Med; 2008; 22(1):66-73. PubMed ID: 18289291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allometric scaling of kidney function in green iguanas.
    Maxwell LK; Jacobson ER
    Comp Biochem Physiol A Mol Integr Physiol; 2004 Jul; 138(3):383-90. PubMed ID: 15313494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allometric scaling of clearance in dogs.
    Martinez M; Mahmood I; Hunter RP
    J Vet Pharmacol Ther; 2009 Oct; 32(5):411-6. PubMed ID: 19754905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacokinetic and tissue distribution investigation of sustained-release cisplatin implants in the normal esophageal submucosa of 12 beagle dogs.
    Yin JX; Wei Z; Xu JJ; Sun ZQ
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):525-36. PubMed ID: 26183605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.
    Paxton JW; Kim SN; Whitfield LR
    Cancer Res; 1990 May; 50(9):2692-7. PubMed ID: 2328494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies scaling of biliary excreted drugs: a comparison of several methods.
    Mahmood I
    J Pharm Sci; 2005 Apr; 94(4):883-92. PubMed ID: 15736194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma iohexol clearance and urinary exogenous creatinine clearance in dogs.
    Finco DR; Braselton WE; Cooper TA
    J Vet Intern Med; 2001; 15(4):368-73. PubMed ID: 11467595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of cisplatin in adult cancer patients.
    de Jongh FE; Gallo JM; Shen M; Verweij J; Sparreboom A
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):105-12. PubMed ID: 15127229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interspecies scaling of renally secreted drugs.
    Mahmood I
    Life Sci; 1998; 63(26):2365-71. PubMed ID: 9877226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraspecies allometry: correlation between kidney weight and glomerular filtration rate vs. body weight.
    Hackbarth H; Büttner D; Gärtner K
    Am J Physiol; 1982 Mar; 242(3):R303-5. PubMed ID: 7065226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of renal function in the rat. The measurement of GFR and ERPF and correlation to body and kidney weight.
    Provoost AP; de Keijzer MH; Wolff ED; Molenaar JC
    Ren Physiol; 1983; 6(1):1-9. PubMed ID: 6836167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates.
    Imai T; Fujii K; Shiraishi S; Otagiri M
    J Pharm Sci; 1997 Feb; 86(2):244-7. PubMed ID: 9040103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allometric basis of enrofloxacin scaling in green iguanas.
    Maxwell LK; Jacobson ER
    J Vet Pharmacol Ther; 2008 Feb; 31(1):9-17. PubMed ID: 18177313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma.
    Fleck C; Hilger R; Jurkutat S; Karge E; Merkel U; Schimske A; Schubert J
    Urol Res; 2002 Sep; 30(4):256-62. PubMed ID: 12202944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs.
    Hardie EM; Page RL; Williams PL; Fischer WD
    Am J Vet Res; 1991 Nov; 52(11):1821-5. PubMed ID: 1686160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.